Advertisement

Topics

Abattis Files Amended and Restated Financial Statements For the Period Ended March 31, 2017

21:21 EDT 9 Aug 2017 | FinanzNachrichten

Vancouver, British Columbia--(Newsfile Corp. - August 9, 2017) - Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis") announces that, as a result of a review by the Bri...

Original Article: Abattis Files Amended and Restated Financial Statements For the Period Ended March 31, 2017

NEXT ARTICLE

More From BioPortfolio on "Abattis Files Amended and Restated Financial Statements For the Period Ended March 31, 2017"

Quick Search
Advertisement